Align Technology appoints Susan E Siegel to board
Ms. Siegel is CEO of GE Ventures and also serves on the board of directors for multiple councils and associations.
Ms. Siegel has 30+ years of experience within corporate companies and venture capital firms.
Prior to GE Ventures, Ms. Siegel was a General Partner at Mohr Davidow Ventures, where she led investments in personalized medicine, digital health, and life sciences.
Before venture capital, she served as president and board member at Affymetrix.
Prior to Affymetrix, Ms. Siegel led strategy, technology development, licensing, manufacturing, as well as new market creation & development at Bio-Rad, DuPont, and Amersham.
Ms. Siegel holds a M.S. in Biochemistry and Molecular Biology from Boston University Medical School and a B.S. in Biology from the University of Puerto Rico.
She currently serves on the boards of the National Venture Capital Association, MIT's The Engine, RAND Health, Stanford Medicine's Board of Leaders, University of California's Innovation Council, Harvard Partners' Innovation Advisory Board, and USC's Schaeffer Center for Health Policy. She is an Aspen Institute Crown Fellow.
Ms. Siegel is expected to stand for election at the Company's next annual meeting of stockholders to be held on May 17, 2017.